Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability.
Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability.
复制标题
DOI：
10.2196/29393
复制
发表时间：
2022-02-07
影响因子：
2.2
通讯作者：
Peterson SK
中科院分区：
文献类型：
--
作者：
Sheshadri A;Makhnoon S;Alousi AM;Bashoura L;Andrade R;Miller CJ;Stolar KR;Arain MH;Noor L;Balagani A;Jain A;Blanco D;Ortiz A;Taylor MS;Stenzler A;Mehta R;Popat UR;Hosing C;Ost DE;Champlin RE;Dickey BF;Peterson SK
基于家庭的肺功能测定（HS）允许早期检测异基因造血细胞移植（AHCT）受者的肺部并发症。尽管HS的可用性和可接受性对于依从性至关重要，但在这种情况下，对HS使用的患者报告结局仍知之甚少。本研究的目的是设计一个纵向的混合方法研究，以了解AHCT接受者中HS的可用性和可接受性。研究参与者使用具有蓝牙功能的肺量计进行HS，该肺量计将肺量计数据真实的传输给研究小组。此外，参与者完成了可用性问卷调查和深入访谈，并报告了他们的经验与HS。访谈数据分析的指导下的性能预期，努力预期，社会影响力的接受和使用技术模型的统一理论的结构。AHCT的接受者认为，尽管存在一些技术障碍，但HS是高度可接受的。平均而言，参与者认为HS有助于管理与AHCT相关的症状（评分范围为2.22 - 2.68，0-4分）和早期发现健康相关问题（评分范围：2.88-3.12）。参与者看好HS，并普遍支持继续使用。从患者的角度来看，没有发现实施的重大障碍。年龄和性别与患者对HS的感知无关。研究参与者认为HS是可接受的，易于使用。一些修改的技术障碍进行HS被确定;然而，从病人的角度来看，更广泛地实施肺部筛查是可行的。
Home-based spirometry (HS) allows for the early detection of lung complications in recipients of an allogeneic hematopoietic cell transplant (AHCT). Although the usability and acceptability of HS are critical for adherence, patient-reported outcomes of HS use remain poorly understood in this setting. The aim of this study is to design a longitudinal, mixed methods study to understand the usability and acceptability of HS among recipients of AHCT. Study participants performed HS using a Bluetooth-capable spirometer that transmitted spirometry data to the study team in real time. In addition, participants completed usability questionnaires and in-depth interviews and reported their experiences with HS. Analysis of interview data was guided by the constructs of performance expectancy, effort expectancy, and social influence from the Unified Theory of Acceptance and Use of Technology model. Recipients of AHCT found HS to be highly acceptable despite modest technological barriers. On average, participants believed that the HS was helpful in managing symptoms related to AHCT (scores ranging from 2.22 to 2.68 on a scale of 0-4) and for early detection of health-related problems (score range: 2.88-3.12). Participants viewed HS favorably and were generally supportive of continued use. No significant barriers to implementation were identified from the patient’s perspective. Age and gender were not associated with the patient perception of HS. Study participants found HS acceptable and easy to use. Some modifiable technical barriers to performing HS were identified; however, wider implementation of pulmonary screening is feasible from the patient’s perspective.